Citations for
1FHA3, KCNJ5
A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S, Hattangady NG, Penton D, Isales C, Edwards MA, Williams TA, Sterner C, Warth R, Mulatero P, Rainey WE.
J Clin Endocrinol Metab Clin Endocrinol Metab. 2013 Sep 13. [Epub ahead of print] 2013
2FHA3, KCNJ5
Role of KCNJ5 in familial and sporadic primary aldosteronism.
Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA.
Nat Rev Endocrinol 9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11. Review. 2013
3FHA3, KCNJ5
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP.
Proc Natl Acad Sci U S A 109(7):2533-8. doi: 10.1073/pnas.1121407109. Epub 2012 Jan 30. 2012
4FHA3, KCNJ3, KCNJ5
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP.
Science 331(6018):768-72. 2011
5FHA3, KCNJ5
Mutations in KCNJ5 gene cause hyperaldosteronism.
Zennaro MC, Jeunemaitre X.
Circ Res 108(12):1417-8. Review. No abstract available. 2011